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DifferentiationThe importance of extracellular calcium in epidermal differentiation and intra-epidermal cohesion has been
recognized for many years. Darier disease (DD) was the ﬁrst genetic skin disease caused by abnormal
epidermal calcium homeostasis to be identiﬁed. DD is characterized by loss of cell-to-cell adhesion and
abnormal keratinization. DD is caused by genetic defects in ATP2A2 encoding the sarco/endoplasmic reticulum
Ca2+-ATPase isoform 2 (SERCA2). SERCA2 is a calcium pump of the endoplasmic reticulum (ER) transporting
Ca2+ from the cytosol to the lumen of ER. ATP2A2mutations lead to loss of Ca2+ transport by SERCA2 resulting
in decreased ER Ca2+ concentration in Darier keratinocytes. Here, we review the role of SERCA2 pumps and
calcium in normal epidermis, and we discuss the consequences of ATP2A2mutations on Ca2+ signaling in DD.
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opean Symposium on Calcium.
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Darier disease (DD) is a rare and severe autosomal dominant skin
disease, with a prevalence estimated around 1 in 50,000, often causing
a considerable handicap [1]. The disease is characterized by keratotic
papules of seborrheic areas of the skin (trunk and face) and folds,
which can form large, crusted, conﬂuent plaques. The skin lesions are
often infected and responsible for major discomfort. The disease
usually starts around puberty, runs a chronic relapsing course, with
exacerbations by UVB irradiation, heat, friction and infections.
Histological examination of skin lesions shows two major features:
loss of cell-to-cell adhesion (acantholysis) leading to suprabasal clefts,
associated with premature and abnormal keratinization (dyskerato-
sis) and the presence of rounded keratinocytes (corps ronds) thought
to correspond to apoptotic cells (Fig. 1). DD is a difﬁcult disease to
treat: oral retinoids are required but often not well tolerated. As a
result, DD is a distressing condition.
We previously identiﬁed ATP2A2 as the defective gene in DD [2].
ATP2A2 encodes the sarco/endoplasmic reticulum Ca2+-ATPase iso-form 2 (SERCA2), a calcium pump transporting Ca2+ from the cytosol
to the lumen of endoplasmic reticulum (ER) [3]. This ﬁnding disclosed
a key role of the SERCA2 pump in cell-to-cell adhesion and abnormal
keratinization, which are major histological features of the disease.
Functional studies of ATP2A2 mutations identiﬁed in DD have shown
that they lead to loss of Ca2+ transport of the pump, sometimes
associated with reduced expression of the mutated pump [4]. As a
consequence of loss of SERCA2 Ca2+ transport, Darier keratinocytes
(DK) display depleted ER Ca2+ stores [5,6].
2. SERCA2
SERCA2 belongs to the P-type Ca2+ ATPase family [7]. SERCA
pumps catalyze the hydrolysis of ATP coupled with the translocation
of two Ca2+ ions from the cytosol to the lumen of the ER, where Ca2+
is stored at a higher concentration. The SERCA2 Ca2+-pump protein
consists of four major domains: a transmembrane (M) domain,
composed of 10–11 transmembrane helices, in which the two Ca2+-
binding sites are located and three cytosolic domains that are the
actuator (A) domain, the phosphorylation (P) domain and the
nucleotide-binding (N) domain. The catalytic cycle of the pump is
based on the transformation between two major conformational
states, designated E1 and E2.
In the E1 conformation, the two Ca2+-binding sites have a high
afﬁnity and are facing the cytoplasm. In the E2 state, the Ca2+-binding
sites have a low afﬁnity and are facing the lumenal side.
Fig. 1. Skin biopsy from Darier disease reveals a suprabasal cleft of the epidermis
containing acantholytic cells, associated with rounded dyskeratotic cells with a dark
nucleus (“corps ronds”) and hyperkeratosis. B is an enlargement of A.
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Alternative splicing of the ATP2A2 gene produces three isoforms,
SERCA2a, 2b and 2c, which differ in their C-termini and are expressed
differently [8,9]. Alternative splicing of exon 20 gives rise to SERCA2a
(997 amino acids) and SERCA2b (1042 amino acids), the latter having
an eleventh transmembrane domain and a tail extending into the ER
lumen (for more information, see [3]). SERCA2c is a more recently
identiﬁed splice variant resulting from the inclusion of a short intronic
sequence containing an in-frame stop codon between exons 20 and 21
of SERCA2a [9]. Although SERCA2a and 2b are detectable in cultured
keratinocytes and ﬁbroblasts [10], SERCA2b is the major isoform
expressed in the epidermis on skin sections. SERCA2a is also
expressed predominantly in cardiomyocytes and slow-twitch skeletal
muscles, but has also been detected in smooth muscle cells [11],
pancreatic epithelial cells [12] and in cerebellar Purkinje cells [13].
SERCA2b is expressed ubiquitously in most tissues. SERCA2c is
expressed in epithelial, mesenchymal and hematopoietic cell lines
and in monocytes [14]. In contrary to uniform distribution of SERCA2a
and SERCA2b in cardiomyocytes of the left ventricle tissue, SERCA2c
was only detected in a conﬁned area of cardiomyocytes, in close
proximity to the sarcolemma [14].
2.2. Functional differences of SERCA2 isoforms
Of all SERCA isoforms, the housekeeping SERCA2b isoform displays
the highest Ca2+ afﬁnity. Upon expression of SERCA2a and SERCA2b
in COS cells, SERCA2b showed a two-fold higher apparent afﬁnity for
Ca2+ but at the same time a two-fold lower catalytic turnover rate
[7,15]. This has been conﬁrmed in vivo by comparing the Ca2+ uptake
in fragmented cardiac sarcoplasmic reticulum (SR) prepared from
mice from which the ATP2A2 gene was altered in such a way that the
animals expressed SERCA2b instead of the normal SERCA2a in their
myocardium [16]. A recent study, using structure–function analysis ofSERCA2b mutants and SERCA1a2b chimera, revealed how the unique
C-terminal extension of SERCA2b controls Ca2+ afﬁnity. Its trans-
membrane (TM) segment (TM11) and luminal extension functionally
cooperate and interact with TM7/TM10 and luminal loops of SERCA2b,
respectively. This stabilizes the Ca2+-bound E1 conformation and
alters Ca2+-transport kinetics, which provides the rationale for the
higher apparent Ca2+ afﬁnity [17]. SERCA2c showed a lower apparent
afﬁnity for cytosolic Ca2+ than SERCA2a and a catalytic turnover rate
similar to SERCA2b [14].
2.3. SERCA2 mutations in Darier disease
More than 130 ATP2A2 mutations have now been reported in DD
patients, the majority of which are different from family to family. The
mutations disrupt critical functional domains of SERCA2 and show no
evidence of clustering or mutations hot spots. Most are missense
mutationsor in-framedeletionsor insertions (63%) (http://www.hgmd.
org). Other mutations predict premature termination codons (PTC) or
abnormal splicing (37%). There is no clear genotype/phenotype
correlation, although missense mutations have been reported to be
associated with a more severe disease phenotype [2]. Most of ATP2A2
mutations affect the three isoforms of SERCA2. However, some patients
present a mutation located in exon 21 which is speciﬁc for SERCA2b.
These mutations lead to a PTC demonstrating that loss of SERCA2b
expression is sufﬁcient to cause DD [18,19]. The fact that SERCA2a
cannot compensate for SERCA2b lossof expression is consistentwith the
fact that SERCA2b is the most prominent isoform in the epidermis.
Site-directed mutagenesis studies have been used to investigate
the effects of ATP2A2mutations on SERCA function [4,20]. In all cases,
DD mutations cause severe disruption of Ca2+ transport function.
Moreover, most mutations markedly affect protein expression,
partially because of enhanced proteasome-mediated degradation
[21]. These data are conﬁrmed in vivo on skin sections from patients
affected with DD, which show decreased SERCA2b expression in the
epidermis of non-lesional and lesional skin compared to control skin.
No difference was seen in SERCA2a expression between patients and
controls [10,22]. Decreased SERCA2 expression in DD patients is
consistent with a mechanism of haploinsufﬁciency (normal pheno-
type requires more gene product than the amount produced by a
single functional copy of the gene). Interestingly, several missense
mutants inhibited the activity of the endogenous and the co-
expressed wild-type SERCA2b. Co-immunoprecipitation experiments
showed that SERCA2b monomers interact to inﬂuence the activity of
each other [21]. Therefore, in addition to haploinsufﬁciency mecha-
nism, a dominant negative mechanism could be envisaged.
3. Calcium and skin
3.1. Calcium gradient in the epidermis
The mammalian epidermis is a highly specialized, highly organized,
stratiﬁed squamous epithelium consisting of basal, spinous, granular
and corniﬁed cell layers. Each layer is deﬁned by distinguishing
morphological and biochemical features and state of differentiation of
the keratinocytes. Epidermal cells undergo a complex program of
terminal differentiation from the basal layers to the corniﬁed layers to
elaborate a protective skin barrier. This program requires the coordi-
nated expression of a large number of genes and tight cell-to-cell
adhesion until epidermal cells enter a desquamation process [23]. The
importance of extracellular calcium in epidermal differentiation and
intra-epidermal cohesion has been recognized for many years [24–26].
The epidermal Ca2+ gradient has been studied using a variety of
techniques, including ion-capture cytochemistry, microbeam proton
induced X-ray emission (PIXE), and Ca2+-sensitive ﬂuorescent dyes
[27–30]. These studies demonstrated the presenceof a total (boundplus
free) Ca2+ gradient which increases progressively from the basal
1113M. Savignac et al. / Biochimica et Biophysica Acta 1813 (2011) 1111–1117epidermal layer to the SG, and then drops abruptly in the stratum
corneum (SC). However, a recent study by Mauro's group using a
combination of two-photon microscopy, FLIM, and phasor analysis of
the data in living tissue allowed much better localization of Ca2+ stores
than those used in previous studies. This study revealed that the bulk of
free Ca2+ measured in the epidermis comes from intracellular Ca2+
stores such as the Golgi and the ER, with extracellular Ca2+ making a
relatively small contribution to the epidermal Ca2+ gradient [31]. The
divergence between the studies is probably due to the fact that previous
studies measured total (free or ionized plus bound) Ca2+ concentra-
tions, whereas this last study measures only free Ca2+. It may be that
total Ca2+ concentrations continue to increase throughout the stratum
spinosum and SG, as Ca2+ is bound to proteins that constitute the
corniﬁed envelopes and keratinohyalin granules, whereas free Ca2+
remains about the same.
Several aspects of the epidermal Ca2+ gradient can be recreated in
vitro. Early differentiation, including the commitment to differentia-
tion, synthesis of differentiation speciﬁc proteins, and formation of
cell-to-cell adhesion, can be mimicked via the “Ca2+ switch,” which
occurs when extracellular Ca2+ ([Ca2+]e) is increased. When isolated
epidermal keratinocytes are cultured at a [Ca2+]e below 0.07 mM,
they proliferate rapidly, express a basal cell phenotype, but fail to
develop intercellular contacts. The differentiation of keratinocytes is
triggered by increasing the [Ca2+]e above 0.1 mM [25]. Elevation of
[Ca2+]e leads to characteristic morphological changes such as
desmosome formation, stratiﬁcation and corniﬁcation.3.2. Calcium signaling in normal keratinocytes
Ca2+ signaling in keratinocytes involves the binding of extra-
cellular Ca2+ to a plasma- membrane Ca2+ receptor (CaR) that is a
G-protein-coupled receptor [32] which activates phospholipase C
(Fig. 2). This generates inositol 1,4,5-trisphosphate (IP3) and
diacylglycerol from phosphatidylinositol bisphosphate. IP3 in turn
acts as a second messenger, binds to its receptors on intracellular
compartments as the ER and the Golgi, to trigger the release of Ca2+
from the intracellular stores into the cytoplasm. The emptying of
intracellular Ca2+ stores activates an inﬂux of extracellular Ca2+CaR
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Fig. 2. Calcium signaling in keratinocytes. The different steps are the following: 1, Ca2+ bindi
by SOCE; 5, Ca2+ is transported by Calmodulin; 6, Calcineurin activation; 7, NFAT dephosphthrough plasma membrane Ca2+ channels, which function like store-
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One speciﬁc type of SOCE, described primarily in immune cells,
is the calcium release– activated current (ICRAC) [33]. Initial
reports of Drosophila TRP activation by store depletion suggested
that mammalian TRP channels would be good candidates to
mediate SOCE [34]. Decreased expression or absence of speciﬁc
TRP proteins can attenuate SOCE, suggesting that TRP channels
directly mediate SOCE [34,35]. Although TRPs may participate in
SOCE, it is presently not accurate to refer to TRP channels as store-
operated channels per se, since the TRP channel with biophysical
properties most closely resembling ICRAC, manifests biophysical
features that are distinct from those of ICRAC [36]. Stromal
interaction molecule (STIM) localized in ER membrane and ORAI
proteins in the plasma membrane are actually the integral
components of SOCE [37,38]. Ca2+ depletion in the ER lumen is
detected by the Ca2+- binding protein STIM1, which oligomerizes
into puncta and relocates to discrete ER-plasma membrane
junctional regions [39,40] where it associates with and activates
ORAI Ca2+ channel. Recently, it has been shown that TRPC1, STIM1
and ORAI1 very likely form ternary complexes to contribute to a
SOC channel (reviewed in [32]). ORAI1 proteins may interact with
TRPCs and act as regulatory subunits that confer STIM1-mediated
store depletion sensitivity to these channels [41,42]. In human
parathyroid cells, STIM1 has been shown to bind to TRPC1, TRPC4,
and TRPC5 and is therefore involved in SOCE [43].
The increase of intracellular Ca2+ levels activates calmodulin, a
major Ca2+-binding protein. This results in the activation of the
cytosolic calmodulin-dependent phosphatase calcineurin, a phospha-
tase that dephosphorylates NFAT, a major Ca2+-dependent transcrip-
tion factor, which allows its translocation into the nucleus and the
induction of downstream target genes. Other transcription factors are
also activated by Ca2+ signaling such as CREB and NFkB.
Following Ca2+ increase in the cytosol, different Ca2+-transport
systems contribute to the removal of Ca2+ from the cytoplasm, thus
setting the [Ca2+]cyto in its resting level: PMCA and NCX localized at
the plasma membrane exclude Ca2+ from cytosol to extracellular
medium; SERCA2 and SPCA1 pumps reﬁll the internal Ca2+ reservoir
of the ER and Golgi, respectively.Golgi
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These paragraphs are illustrated in Fig. 3.
4.1. Calcium signaling in Darier keratinocytes
As a consequence of the loss of SERCA2 Ca2+ transport on Ca2+
homeostasis, Darier keratinocytes display depleted ER Ca2+ stores
[5,6]. However, the consequences of this depletion of Ca2+ stores
on intracellular Ca2+ ([Ca2+]cyto) remains controversial. Leinonen
et al. have shown that [Ca2+]cyto is increased in DD keratinocytes,
while Foggia et al. have shown a decrease in [Ca2+]cyto as a result of
upregulation of ATP2C1, which encodes the secretory pathway Ca2+/
Mn2+-ATPase (SPCA1), the Ca2+ pump of the Golgi apparatus. In the
same study, inhibition of ATP2C1 by small interfering RNA diminished
Darier keratinocyte viability, which indicates that upregulation of
ATP2C1 is a compensatory mechanism preventing apoptosis. Another
compensatorymechanismwasdemonstratedbyPani et al.who showed
up-regulation of transient receptor potential canonical channel 1
(TRPC1), a plasma membrane capacitative entry channel [44]. These
authors showed that overexpression of TRPC1 enhanced cell prolifer-
ation and restricted apoptosis. Therefore, compensatory mechanisms
both at the level of intracellular and plasma membrane pumps are
present in Darier keratinocytes, aiming at restoring normal Ca2+
intracellular concentration. In vivo, the calcium content of the basal
layer in non-lesional and lesional DD skinwas reported to be lower than
in the normal skin [45].
4.2. ER stress and apoptosis
The ER plays a key role in post-translational modiﬁcations of
proteins associated with the plasma membrane. Depletion of Ca2+ ER
stores has the potential to impair post- translational modiﬁcations in
the protein secretory pathway and to trigger the ER stress response
induced by stressors [46]. This is particularly relevant to the
observation that DD lesions are triggered/exacerbated by various
stress conditions, as UVB irradiation, heat, infection, friction. ExposureFig. 3. Consequences of SERCA2 mutations in Darier keratinocytes. SERCA2 mutations ind
Compensatory effects in Ca2+ signaling include up-regulation of SPCA1 and TRPC1 express
chaperone protein expression (4). Persistent ER stress in Darier keratinocytes leads to apopt
illustrated by desmoplakin immundetection by immunoﬂuorescence, is associated with lo
(involucrin expression is enhanced and premature, K10 and K14 are co-expressed, 7).to these stresses could unmask the relative depletion of ER Ca2+
stores and trigger an ER stress that Darier keratinocytes would not be
able to control because of their limited capacity to increase the level of
functional SERCA2 pump [47]. Consistent with this, ultraviolet B
irradiation and pro-inﬂammatory cytokines have been shown to
down-regulate ATP2A2 mRNA expression [48]. Moreover, the expres-
sion of ER chaperones (calreticulin, BiP) and the ER stress-transcrip-
tion factor CHOP is enhanced in thapsigargin-stimulated Darier
keratinocytes as compared to controls [49]. In Darier keratinocytes,
persistent ER stress which cannot be overcome because of defective
up-regulation of SERCA2 could result in apoptotic keratinocytes as
observed in DD (“corps ronds”).
Bcl-2 gene family proteins play a major role in the regulation of
apoptosis in keratinocytes and in intracellular Ca2+ homeostasis. For
these reasons, the expression of Bcl-2 gene family proteins has been
investigated in DD skin. The expression of Bcl-2 and Bcl-xL was clearly
reduced in the lesional epidermis of the patients, as compared with
normal epidermis of healthy controls, whereas the expression of Bax
remained unaltered [50,51]. These alterations could contribute to the
activation of the apoptotic process in the lesional epidermis of DD
patients and for the occurrence of the characteristic dyskeratotic
keratinocytes.
4.3. Desmosomes
One of the histopathological features of Darier disease is
suprabasal cleavage resulting from impaired desmosome formation
leading to acantholysis [52]. Several studies have provided evidence
for the role of SERCA2 in the assembly of the desmosomal complex.
In these studies, the authors used thapsigargin (TG), a SERCA
inhibitor, to investigate the role of SERCA in the formation of different
adhesion complexes. TG impaired the formation of desmosomes and
tight junctions during polarized epithelial cell biogenesis [53]. Our
laboratory has demonstrated that SERCA inhibition by TG in normal
human keratinocytes impairs the trafﬁcking of the desmoplakins,
desmoglein, and desmocollin to the cell surface. In the same study, we
showed that only the trafﬁcking of desmoplakin and not of the otheruce a loss of Ca2+ transport by the pump (1), leading to a decrease of [Ca2+]ER (2).
ion (3). The depletion of Ca2+ ER stores triggers an ER stress response with increased
osis (Bcl-2 and Bcl-xL expression is decreased). (5) Impaired desmoplakin trafﬁcking, as
ss of cell-to-cell adhesion (6). Differentiation in Darier keratinocytes is also perturbed
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[18]. Defective addressing to the desmosomal plaque of desmoplakin,
which links the cytoskeleton to the desmosomal complexes, could
contribute to impair cell-to-cell adhesion in DD epidermis.
4.4. Differentiation
The histopathological features of DD include, in addition to
suprabasal acantholysis, an abnormal differentiation of single cells
(dyskeratosis) so-called corps ronds and grains of Darier. DD lesions
show also hyperkeratosis (thickening of the stratum corneum) (ortho
or parakeratosis) often with papillomatosis. DD skin shows a major
increase in involucrin staining [54]. More recently, DD lesional skin
was reported to display premature and enhanced expression of
involucrin with a strong labeling in keratinocyte cell membrane and
cytoplasm in the lower epidermal layers [55]. However, similar
abnormalities in involucrin expression are also seen in other
keratinization disorders including psoriasis [56], atopic dermatitis
[57], lamellar ichtyosis [58,59]. In addition, the transition of keratin 14
to keratin 10 was abnormal in DD lesions as demonstrated by the
presence of keratinocytes expressing both cytokeratins, which are
usually exclusive in normal epidermis [45].
The epidermal differentiation complex (EDC) on chromosome
1q21 contains many genes associated with epidermal terminal
differentiation such as S100, small proline-rich region (SPRR) and
the late corniﬁed envelope (LCE) genes. LCE genes respond to
environmental stimuli such as calcium levels and ultraviolet light
[60], and therefore, their expression in DD keratinocytes is likely
modiﬁed.
5. Why only the skin is affected?
SERCA2 is expressed, in addition to the skin, in the brain and in the
heart. Neuropsychiatric abnormalities have been frequently reported
by dermatologists in Darier patients, but their speciﬁcity has been
debated for a long time. Recently, a systematic investigation of the
neuropsychiatric phenotype has been performed in 100 DD patients.
Half of DD patients have mood disorders, speciﬁcally major
depression (30%), bipolar disorder (4%), suicide attempts (13%) or
suicidal thoughts (31%) [61]. These were more common in DD when
compared with general population data. The prevalence of epilepsy
(3%) in the patients was also higher than the prevalence in the general
population [61]. There was no consistent association of speciﬁc
dermatological features of DD and the presence of psychiatric
features. It is not known if neuropsychiatric symptoms are a
psychological reaction to having a skin disease or a direct conse-
quence of mutations in the ATP2A2 gene.
Concerning heart abnormalities in DD, the incidence of heart
disease does not appear to be increased in DD [62,63] and cardiac
performance in these patients is normal [64,65], suggesting that a
reduction in SERCA2 levels may not be a signiﬁcant factor in human
heart disease.
Therefore, APT2A2 mutations cause clinical symptoms only to the
epidermis and predominately to certain areas of skin (seborrhoeic
areas). Although the reason is not clear, several explanations can be
proposed. Compensatory mechanisms could be induced in the other
tissues. Indeed, all tissues that express SERCA3 co-express SERCA2b,
except for the epidermis [66]. Therefore, SERCA3 could compensate
the defect of SERCA2 in non-cutaneous tissues. Another explanation
could be that the requirement of epidermal cells in SERCA2 pumps is
more important than in other tissues and that half of the normal
quantity of SERCA2 pumps is not sufﬁcient to achieve correct function
in the epidermis (tissue-speciﬁc gene dosage effect), whereas it is
sufﬁcient in other tissues. This could also explain why the disease is
exacerbated by external factors such as heat, UV exposure, friction,
and infection. Dysfunction of the SERCA2 pump would be compen-sated by other mechanisms at the basal state, but exposure to stress
would require an increase in SERCA2 activity to a level that the cells
cannot achieve, owing to the loss of function of one copy of the gene.
This would disrupt a subtle balance and lead to clinical symptoms of
the disease.
6. Mouse models
SERCA2 knockout is lethal in mice. Studies in SERCA2+/– mice
have revealedmajor differences in the effect of SERCA2 dysfunction in
humans and mice. These heterozygous mice appear healthy with only
mild impairment of cardiac contractility and relaxation due to
reductions of SERCA2 mRNA, protein, and activity levels [67,68].
These mice do not develop Darier-like lesions, but with age, develop
squamous epithelial papillomas and carcinomas [69,70]. In contrast,
haploinsufﬁciency does not appear to increase the incidence of
squamous-cell skin cancer in humans. Recently, Andersson and al.
have developed a mouse carrying a conditional SERCA2 ﬂoxed allele
which allows disruption of the Serca2 gene in an organ-speciﬁc and/or
inducible manner [71]. This Serca2ﬂox mouse is the ﬁrst murine
conditional gene disruption model for the SERCA family of Ca2+
ATPases, and should be a powerful tool for investigating speciﬁc
physiological roles of SERCA2 function in a range of tissues and organs
in vivo, notably in the skin.
7. Conclusions
The importance of Ca2+ in skin biology has long been recognized.
The implication of SERCA2 pump in Darier disease demonstrates the
importance of calcium homeostasis in skin biology. Darier disease
represents a disease model to study the effects of Ca2+ ER depletion
on Ca2+ signaling in the epidermis. A better understanding of the
molecular mechanisms involved in the disruption of the balance
leading to the clinical symptoms, has the potential to identify new
therapeutic targets.
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